Plaintiff Says Arava Manufacturer Breached Duty to Warn of Risks



DOCUMENTS
  • Complaint


TALLAHASSEE, Fla. - A Florida woman seeking damages against Sanofi-Aventis U.S. Inc. has accused the manufacturer of negligently failing to warn that ingesting the rheumatoid arthritis drug Arava could cause serious hematologic abnormalities. Prater v. Sanofi-Aventis U.S. Inc., No. 06-560 (N.D. Fla.).

In a Dec. 8 complaint filed in the U.S. District Court for the Northern District of Florida, Charlene Prater alleges that her use of Arava (leflunomide) as prescribed caused her to suffer several adverse side effects, including pancytopenia and erythma multiforme.

According to the complaint, Arava is defective in design because it has 'a dangerously long half life …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Hotel Details in Tucson, Arizona, to be Announced

MORE DETAILS